Red cell survival studies in a patient with anti-Tca.
A radiolabeled, allogenic red cell survival study was performed on a patient who lacked the Cromer-related antigen Tca and who had developed the corresponding antibody. Red cell survival was 92% at 1 hour and 88% at 24 hours. Monocyte monolayer assays (MMA) and IgG subclass determinations were performed on samples from: (1) 1965, the period of initial antibody formation; (2) approximately two years before the red cell survival study; and (3) four months after the study. All samples reacted w+ to 1+ by the antiglobulin test. The earliest sample contained IgG1, IgG2, and IgG4 anti-Tca. Because there were 20.5% reactive monocytes in the MMA (normal range 0-3%), this antibody may have produced extravascular red cell destruction. In contrast to the initial example, the samples before and after the red cell survival study both contained IgG2 and IgG4 subclasses with 1.3% and 2.2% MMA reactivity, respectively. The current pattern of antibody subclass, the lack of reactivity in the MMA, and a red cell survival of 88% at 24 hours indicate that short-term transfusion support would have been well tolerated. This contrasts to the in vitro results obtained with the earliest sample, which suggest a clinically significant antibody. This appears to be the first report of a red cell alloantibody that remained serologically reactive but underwent a loss of its IgG1 fraction, which appeared capable of red cell destruction based on the MMA results.
Anderson
G
G
Blood Bank and Transfusion Service, University of Virginia Health Sciences Center, Charlottesville 22908.
Gray
L S
LS
Mintz
P D
PD
D000368:Aged; D002470:Cell Survival; D004912:Erythrocytes / Q000502:physiology*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000032:analysis*; D013997:Time Factors
D007518:Isoantibodies